These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6261944

  • 1. Phase II study of spirogermanium in advanced ovarian malignancy.
    Tropé C, Mattsson W, Gynning I, Johnsson JE, Sigurdsson K, Orbert B.
    Cancer Treat Rep; 1981; 65(1-2):119-20. PubMed ID: 6261944
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.
    Weiselberg L, Budman DR, Schulman P, Vinciguerra V, Degnan TJ, Pasmantier M.
    Cancer Treat Rep; 1982 Aug; 66(8):1675-6. PubMed ID: 7201885
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II trial of spirogermanium for treatment of advanced breast cancer.
    Falkson G, Falkson HC.
    Cancer Treat Rep; 1983 Feb; 67(2):189-90. PubMed ID: 6825129
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase II study of spirogermanium in advanced breast cancer.
    Kuebler JP, Tormey DC, Harper GR, Chang YC, Khandekar JD, Falkson G.
    Cancer Treat Rep; 1984 Dec; 68(12):1515-6. PubMed ID: 6509457
    [No Abstract] [Full Text] [Related]

  • 11. Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.
    Boros L, Tsiatis AA, Neiman RS, Mann RB, Glick JH.
    Cancer Treat Rep; 1986 Jul; 70(7):917-8. PubMed ID: 3719586
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A phase II study of spirogermanium in advanced human malignancy.
    Vogelzang NJ, Gesme DH, Kennedy BJ.
    Am J Clin Oncol; 1985 Aug; 8(4):341-4. PubMed ID: 3909806
    [Abstract] [Full Text] [Related]

  • 18. Phase II evaluation of bleomycin in patients with advanced epithelial ovarian cancer.
    Blackledge G, Lawton F, Buckley H, Crowther D.
    Cancer Treat Rep; 1984 Mar; 68(3):549-50. PubMed ID: 6200221
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.